Capital Advisors Ltd’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Capital Advisors Ltd's BSX Position: Q2 2026 in Review
Capital Advisors Ltd reduced its Boston Scientific (BSX) stake by 32% in Q2 2026, selling an estimated $11.1K and leaving 445 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #701.
Capital Advisors Ltd first reported a position in BSX in Q4 2021 and has held it in 18 quarters since. The position peaked at $58K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Capital Advisors Ltd held 445 shares of Boston Scientific worth $19K as of Q2 2026.
- Capital Advisors Ltd sold 205 Boston Scientific shares in Q2 2026, an estimated $11.1K.
- Boston Scientific made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #701 holding.
- Capital Advisors Ltd first reported a position in Boston Scientific in Q4 2021 and has held it in 18 quarters since.
- Capital Advisors Ltd's Boston Scientific position peaked at $58K in Q2 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.